1. Stocks
    2. /
  2. CSL (ASX: CSL)
    3. /

CSL (ASX: CSL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

CSL Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • CSL (ASX: CSL)
    Latest News

    Stock market chart in green with a rising arrow symbolising a rising share price.
    Record Highs

    Breaking: The ASX 200 just hit a new all-time high

    | Sebastian Bowen

    Australian shares have exploded 16.8% higher in two months.

    Read more »

    A businessman lights up the fifth star in a lineup, indicating positive share price for a top performer
    Share Market News

    3 of the best ASX 200 shares to buy in June

    | James Mickleboro

    Let's see which shares are being rated as top buys by brokers.

    Read more »

    Shot of two young scientists using a laptop in a laboratory.
    Healthcare Shares

    Buying CSL shares? Meet your new board director

    | Bernd Struben

    CSL’s new board director has spent the last 11 years in an executive role at Australia’s $240 billion Future Fund.

    Read more »

    Person handing out $50 notes, symbolising ex-dividend date.
    Broker Notes

    Where to invest $20,000 into ASX 200 shares

    | James Mickleboro

    Brokers think these shares could be top picks for Aussie investors.

    Read more »

    Warren Buffett
    Opinions

    Three ASX 200 shares Warren Buffett could buy

    | Steve Holland

    If Warren Buffett had to add three ASX shares to his portfolio, he would likely look at these three top…

    Read more »

    A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
    Broker Notes

    Bell Potter names the best ASX 200 stocks to buy in June

    | James Mickleboro

    The broker is feeling bullish on these names this month. Let's find out why.

    Read more »

    A man holding a cup of coffee puts his thumb up and smiles while at laptop.
    Blue Chip Shares

    3 high-conviction ASX 200 shares I'd buy in June

    | James Mickleboro

    Let's see why these strong stocks could be top picks for investors this month.

    Read more »

    Man smiling at a laptop because of a rising share price.
    Broker Notes

    9 ASX 200 shares just upgraded to strong buy ratings

    | Bronwyn Allen

    Brokers have upgraded these shares amid expectations of price growth over the next 12 months.

    Read more »

    Piggy bank at the end of a winding road.
    Opinions

    My top 3 picks in the ASX 20 in June

    | Sebastian Bowen

    I think these stocks stand out from the rest of the ASX 20 pack.

    Read more »

    A man holding a cup of coffee puts his thumb up and smiles while at laptop.
    How to invest

    How ASX 200 stocks and ASX ETFs can be combined to build the perfect portfolio

    | James Mickleboro

    Want to build a strong portfolio? Then take a look at this strategy.

    Read more »

    ETF written in yellow with a yellow underline and the full word spelt out in white underneath.
    ETFs

    3 ASX ETFs for a $500 investment

    | James Mickleboro

    These funds offer investors access to companies both locally and across the globe.

    Read more »

    Ecstatic woman looking at her phone outside with her fist pumped.
    Blue Chip Shares

    3 super strong ASX 200 blue chip shares to buy now

    | James Mickleboro

    These blue chips have been given a big thumbs up by brokers.

    Read more »

    Frequently Asked Questions

    CSL was listed on the ASX in June 1994.

    CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.

    Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.

    CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.

    CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents. 

    CSL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About CSL

    CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.

    CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.

    CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).

    The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.

     

    Profile

    since

    Note